Synthego Launches Molecular Reagents for Diagnostics & Research
Synthego is expanding its core mission to accelerate life sciences research and clinical development with the launch of a comprehensive portfolio of high-performance molecular reagents. Building upon our established leadership in CRISPR genome engineering, this strategic expansion provides essential, high-quality tools to support the entire research and diagnostic workflow. This new portfolio is engineered to deliver the precision, performance, and reliability required to advance molecular biology and drive innovation in the field of clinical and molecular diagnostics.